Skip to main content
. Author manuscript; available in PMC: 2013 Jan 28.
Published in final edited form as: Biotechnol Bioeng. 2010 Apr 15;105(6):1078–1093. doi: 10.1002/bit.22635

Figure 6.

Figure 6

Magnetophoretic mobility of human PBL labeled with anti-CD3-PE and anti-PE MACS particles. The labeling concentration was 40 ul for the anti-CD3-PE and 5 times the company recommended value for the anti-PE-MACS. (adapted from Lara et al. 2006)